West Coast Financial LLC Acquires 600 Shares of iShares Biotechnology ETF (NASDAQ:IBB)

West Coast Financial LLC grew its stake in iShares Biotechnology ETF (NASDAQ:IBBFree Report) by 25.0% in the first quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 3,000 shares of the financial services provider’s stock after buying an additional 600 shares during the period. West Coast Financial LLC’s holdings in iShares Biotechnology ETF were worth $412,000 as of its most recent SEC filing.

Several other large investors also recently made changes to their positions in the stock. International Assets Investment Management LLC acquired a new stake in shares of iShares Biotechnology ETF in the fourth quarter valued at about $76,425,000. Global Assets Advisory LLC bought a new stake in shares of iShares Biotechnology ETF in the first quarter valued at approximately $66,059,000. Itau Unibanco Holding S.A. acquired a new stake in shares of iShares Biotechnology ETF in the third quarter worth $48,242,000. Raymond James Financial Services Advisors Inc. increased its position in iShares Biotechnology ETF by 8.9% during the fourth quarter. Raymond James Financial Services Advisors Inc. now owns 153,692 shares of the financial services provider’s stock worth $20,879,000 after acquiring an additional 12,611 shares during the period. Finally, Stifel Financial Corp raised its stake in iShares Biotechnology ETF by 11.7% during the 4th quarter. Stifel Financial Corp now owns 137,897 shares of the financial services provider’s stock valued at $18,736,000 after purchasing an additional 14,457 shares during the last quarter. Institutional investors own 62.45% of the company’s stock.

iShares Biotechnology ETF Stock Performance

NASDAQ:IBB traded down $0.03 during trading hours on Tuesday, reaching $139.93. The company had a trading volume of 940,940 shares, compared to its average volume of 1,654,797. The stock has a 50-day moving average of $133.41 and a two-hundred day moving average of $134.58. iShares Biotechnology ETF has a one year low of $111.83 and a one year high of $141.16.

About iShares Biotechnology ETF

(Free Report)

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.

Read More

Want to see what other hedge funds are holding IBB? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for iShares Biotechnology ETF (NASDAQ:IBBFree Report).

Institutional Ownership by Quarter for iShares Biotechnology ETF (NASDAQ:IBB)

Receive News & Ratings for iShares Biotechnology ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for iShares Biotechnology ETF and related companies with MarketBeat.com's FREE daily email newsletter.